Halozyme Therapeutics, Inc. $(HALO)$ is currently at $46.88, down $7.08 or 13.12%
--Would be lowest close since June 5, 2024, when it closed at $45.65
--On pace for largest percent decrease since Jan. 13, 2016, when it fell 17.68%
--Currently down four consecutive days; down 23.26% over this period
--Longest losing streak since Oct. 25, 2024, when it fell for five straight trading days
--Worst four day stretch since the four days ending Jan. 19, 2016, when it fell 25.2%
--Down 7.3% month-to-date
--Up 26.84% year-to-date; on pace for best year since 2022, when it rose 41.51%
--Down 27.23% from its all-time closing high of $64.42 on Aug. 28, 2024
--Up 17.41% from 52 weeks ago (Nov. 17, 2023), when it closed at $39.93
--Down 27.23% from its 52-week closing high of $64.42 on Aug. 28, 2024
--Up 39.19% from its 52-week closing low of $33.68 on Feb. 5, 2024
--Traded as low as $45.71; lowest intraday level since June 5, 2024, when it hit $44.38
--Down 15.29% at today's intraday low; largest intraday percent decrease since March 18, 2020, when it fell as much as 15.38%
All data as of 11:42:21 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 15, 2024 11:46 ET (16:46 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。